Resources Contact Us Home
Clostridium perfringens alpha toxin proteins

Image Number 10 for United States Patent #7982006.

This invention pertains in part to the development of a vaccine for poultry against necrotic enteritis (NE). The vaccine utilizes a protective antigen that is a mutated, full-length, non-toxic Clostridium perfringens (Cp) .alpha.-toxin protein (Mcpa). Utility of this vaccine was demonstrated by reduction of lesion severity in NE challenge trails, for example. Also disclosed herein are novel approaches for producing this vaccine in significant quantities. One exemplified approach involves producing NE vaccine (mutated alpha toxin) in bacterial expression systems, preferably utilizing the Pseudomonas fluorescens system, for commercial use in controlling NE in the poultry industry. The subject vaccines can be administered preferably to chickens in several different ways. A novel, Type VI alpha toxin from chicken isolates of Cp is also disclosed.

  Recently Added Patents
Oscillation circuit
Analysis of stress impact on transistor performance
Magnetic impedance element and magnetic sensor using the same
Dual source mass spectrometry system
End-of-session authentication
Semiconductor device including a clock generating circuit for generating an internal signal having a coarse delay line, a fine delay line and a selector circuit
Systems and methods for parameter adaptation
  Randomly Featured Patents
Flame retardant, low smoke emission, halogen free 600 V energy cable with polyolefin insulation and polyamide jacket
Method and apparatus for moulding and curing tyres for vehicle wheels
Control system for combined digital video signal receiver and recording/reproducing apparatus
Computed tomography system with translatable focal spot
Lamp or hangable accessory
Footwear upper
Stackable package
Thermostable strains of the genus thermus capable of producing a .beta. lactosidase
Golf club holder
Blocking cell adhesion molecules and treating animals with ocular inflammation